...
首页> 外文期刊>European journal of pharmaceutics and biopharmaceutics: official journal of Arbeitsgemeinschaft fuer Pharmazeutische Verfahrenstechnik e.V >Development and characterization of fast-dissolving tablet formulations of glyburide based on solid self-microemulsifying systems
【24h】

Development and characterization of fast-dissolving tablet formulations of glyburide based on solid self-microemulsifying systems

机译:基于固体自微乳化系统的格列本脲速溶片剂的研制与表征

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of this work was to develop effective fast-dissolving tablet formulations of glyburide, endowed with improved dissolution and technological properties, investigating the actual effectiveness of the Solid-Self MicroEmulsifying Drug Delivery System (S-SMEDDS) approach. An initial screening aimed to determine the solubility of the drug in different oils, Surfactants and CoSurfactants allowed the selection of the most suitable components for liquid SMEDDS, whose relative amounts were defined by the construction of pseudo-ternary phase diagrams. The selected liquid SMEDDS formulations (Capyol 90 as oil, Tween 20 as Surfactant and Glycofurol or Transcutol as CoSurfactant) were converted into Solid-SMEDDS, by adsorbing them onto Neusilin (1:1 and 1:0.8 w/w S-SMEDDS:carrier), and fully characterized in terms of solid state (DSC and X-ray powder diffraction), morphological (ESEM) and dissolution properties, particle size and reconstitution ability. Finally, the 1:1 S-SMEDDS containing Glycofurol as CoSurfactant, showing the best performance, was selected to prepare two final tablet formulations. The ratio test (t(10 min) ratio and DE60 ratio) and pair-wise procedures (difference (f(1)) and similarity (f(2)) factors) highlighted the similarity of the new developed tablets and the marked difference between their drug dissolution profiles and those of formulations based on the micronized drug. The S-SMEDDS approach allowed to develop fast-dissolving tablets of glyburide, endowed with good technological properties and able to achieve the complete drug dissolution in a time ranging from 10 to 15 min, depending on the formulation composition. (C) 2016 Elsevier B.V. All rights reserved.
机译:这项工作的目的是开发具有改善的溶出度和技术特性的格列本脲快速有效的片剂制剂,研究固体自微乳化药物递送系统(S-SMEDDS)方法的实际有效性。旨在确定药物在不同油类,表面活性剂和助表面活性剂中的溶解度的初步筛选允许选择最适合液体SMEDDS的组分,其相对量由伪三元相图的构建定义。通过将所选的液体SMEDDS制剂(油中的Capyol 90,表面活性剂的Tween 20和作为辅助表面活性剂的Gycofurol或Transcutol)吸附到Neusilin(1:1和1:0.8 w / w S-SMEDDS:载体)上,将其转化为固体SMEDDS。 ),并在固态(DSC和X射线粉末衍射),形态学(ESEM)和溶解特性,粒度和重构能力方面具有充分的特征。最后,选择显示出最佳性能的含有甘草醇作为辅表面活性剂的1:1 S-SMEDDS来制备两种最终的片剂。比率测试(t(10分钟)比率和DE60比率)和成对程序(差异(f(1))和相似性(f(2))因子)突出显示了新开发的片剂的相似性以及两者之间的显着差异它们的药物溶出曲线以及基于微粉化药物的制剂的溶出曲线。 S-SMEDDS方法允许开发格列本脲速溶片剂,该片剂具有良好的技术性能,并且能够根据制剂组成在10到15分钟的时间内实现药物的完全溶解。 (C)2016 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号